Meena M, Ph.D.

Vice President of Bioanalytical, DMPK and Biomarker Development
Stoke Therapeutics, Inc.

Poster(s):

• (M1130-06-40) Development and Validation of a Sensitive Hybridization-Electrochemiluminescence (H-ECL) Method for Quantitation of STK-002, an Antisense Oligonucleotide, in Human Serum
  Monday, October 23, 2023

  11:30 AM – 12:30 PM ET

• (M1330-10-64) Evaluation of In Vitro Protein Binding of STK-001, an Antisense Oligonucleotide, in Plasma and Cerebrospinal Fluid
  Monday, October 23, 2023

  1:30 PM – 2:30 PM ET